For the first time, the FDA approved an AI-based device to detect disease without a clinician. It’s the latest in a string of nods toward digital health from the agency, like AliveCor’s clearance for its EKG Apple Watch app. FDA boss Gottlieb stated the agency is also seeking a precertification approach for regulating continually-evolving AI healthcare software—a reason for cautious optimism for digital health.
How do you evaluate the crowded AI startup landscape and emerging regulatory paradigm? Come to our forum—we’re discussing that topic and more with UCSF's Bob Wachter, J&J's Rowan Chapman, and GSK's John Baldoni, among others.
A new era for AI: FDA approves retinopathy-detecting software (The Verge)
Correctly detecting disease 87% of the time, the software does not require specialist interpretation
Wojcicki fights claims that consumers need experts to interpret genetic tests (STAT)
23andMe founder compares fear to early skepticism about at-home pregnancy tests
CVS launches digital tool to help patients save money (Washington Post)
Study shows doctors switch patients to cheaper, covered drugs 85% of the time
Two experts debate whether Facebook should get into health (CNBC)
"The divide between 'social data' and 'health care data' is pretty artificial"
Half of EHR-using doctors want better access to patient data (MobiHealthNews)
88% said access to patient history data is a priority